Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions
暂无分享,去创建一个
M. Tetzlaff | V. Prieto | P. Harms | S. Billings | J. Ko | A. Andea | I. Kovalyshyn | Eugen C. Minca | Rami N. Al-Rohil | A. Collie | Min Wang | R. Al-Rohil
[1] A. Gutin,et al. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma , 2015, Journal of cutaneous pathology.
[2] L. Clarke,et al. A CLINICALLY VALIDATED GENE EXPRESSION SCORE IMPACTS DIAGNOSIS AND MANAGEMENT RECOMMENDATIONS OF MELANOCYTIC LESIONS BY DERMATOPATHOLOGISTS , 2015 .
[3] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[4] N. Kolaitis,et al. Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms: A Review of 804 Cases , 2014, The American journal of surgical pathology.
[5] M. Tetzlaff,et al. Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses , 2013, The American journal of surgical pathology.
[6] K. Busam,et al. Cytogenetic and mutational analyses of melanocytic tumors. , 2012, Dermatologic clinics.
[7] J. Guitart,et al. A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms , 2012, The American journal of surgical pathology.
[8] S. Lyle,et al. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. , 2012, Archives of pathology & laboratory medicine.
[9] P. Gerami,et al. Fluorescence in situ hybridization for ambiguous melanocytic tumors. , 2012, Histology and histopathology.
[10] J. Guitart,et al. Melanocytic Nevi With An Atypical Epithelioid Cell Component: Clinical, Histopathologic, and Fluorescence In Situ Hybridization Findings , 2011, The American journal of surgical pathology.
[11] R. Gasparini,et al. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions , 2011, Diagnostic pathology.
[12] V. de Giorgi,et al. Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. , 2011, Journal of the American Academy of Dermatology.
[13] L. Cerroni,et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases , 2011, Modern Pathology.
[14] K. Busam,et al. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus‐like melanoma , 2011, Journal of cutaneous pathology.
[15] S. Purcell. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up , 2011 .
[16] J. Guitart,et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. , 2010, Archives of dermatology.
[17] S. Jhanwar,et al. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization , 2010, Journal of cutaneous pathology.
[18] N. Kolaitis,et al. Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma , 2010, The American journal of surgical pathology.
[19] J. Guitart,et al. Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization , 2009, The American journal of surgical pathology.
[20] L. Morrison,et al. Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma , 2009, The American journal of surgical pathology.
[21] J. Guitart,et al. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma , 2009, Modern Pathology.
[22] S. Lodha,et al. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting , 2008, Journal of cutaneous pathology.
[23] Sing Kai Lo,et al. Interobserver Reproducibility of Histopathologic Prognostic Variables in Primary Cutaneous Melanomas , 2003, The American journal of surgical pathology.
[24] D. Elder,et al. Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. , 2002, Archives of dermatology.
[25] R. Corona,et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] E. DeLong,et al. Intermediate, Indeterminate, and Uninterpretable Diagnostic Test Results , 1987, Medical decision making : an international journal of the Society for Medical Decision Making.